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Abstract Mitochondrial tRNA mutations are one of the important causes of both syndromic and non-syndromic deafness.
Of those, syndromic deafness-associated tRNA mutations such as tRNALeu(UUR) 3243A>G are often present in heteroplasmy,
while non-syndromic deafness-associated tRNA mutations including tRNASer(UCN) 7445A>G are often in homplasmy or in
high levels of heteroplasmy. These tRNA mutations are the primary mutations leading to hearing loss. However, other
tRNA mutations such as tRNAThr 15927G>A and tRNASer(UCN) 7444G>A may act in synergy with the primary mitochondrial
DNA mutations, modulating the phenotypic manifestation of the primary mitochondrial DNA mutations. Theses tRNA
mutations cause structural and functional alteration. A failure in tRNA metabolism caused by these tRNA mutations
impaired mitochondrial translation and respiration, thereby causing mitochondr ial dysfunctions responsible for
deafness. These data offer valuable information for the early diagnosis, management and treatment of maternally inherited
deafness.
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Introduction
Deafness is one of the most common human health
problems, affecting one in 700~1000 newborns (Morton,
1991). Deafness can be caused by gene alterations and
environmental factors including ototoxic drugs such as
aminoglycoside antibiotics (Morton, 2002). Deafness
can be grouped into syndromic deafness (hearing loss
with other medical problems such as diabetes), and
non-syndromic deafness (hearing loss is the only obvious
medical problem). Mutations in mitochondrial DNA
(mtDNA) have been found to be associated with both
maternally transmitted syndromic and non-syndromic
deafness (Fischel-Ghodsian, 2004; Jacobs et al., 2005;
Xing et al., 2007; Guan, 2011). These mtDNA mutations
include point mutations, deletions and duplications
(Guan, 2004). Of those point mutations, the 1555A>G
and 1494C>T mutations in the 12S rRNA gene have
been associated with aminoglycoside ototoxicity and
non-syndromic deafness in many families worldwide
(Fischel-Ghodsian, 2004; Lu et al., 2010; Guan, 2011).
Mitochondrial tRNA genes are another hot spots for muta⁃
tions associated with both syndromic and non-syndromic
hearing loss (Guan, 2004; Xing et al., 2007). In this
review, we summarized deafness-associated mitochondrial
tRNA mutations and discussed the molecular pathogenetic
mechanism of deafness associated tRNA mutations.
Mitochondrial tRNA
Human cells contain from hundreds to thousands of
copies of mtDNA molecules (Wallace, 1999). Human
mtDNA is a double-strand circular molecule with 16,569
base pairs encoding 37 genes: 13 for essential subunits of
the oxidative phosphorylation (OXPHOS) system, 2 for
rRNAs and 22 for tRNAs required for the mitochondrial
protein synthesis (Anderson et al., 1981; Wallace, 1999).
Among these tRNAs, tRNAGlu, tRNAA1a, tRNAAsn,
tRNACys, tRNATyr, tRNASer(UCN), tRNAGln and tRNAPro are
resided at the cytosine-rich light (L) strand, the remaining
tRNAPhe, tRNAVal, tRNALeu(UUR), tRNALeu(CUN), tRNAIle,
tRNAMet, tRNASer(AGY), tRNATrp, tRNAAsp, tRNALys, tRNAGly,
tRNAArg, tRNAHis and tRNAThr are located at the guanine-rich
heavy (H) strand (Anderson et al., 1981).
As shown in Figure 1, tRNAs often form a highly
conserved cloverleaf structure. The folded L-shaped
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tertiary structure of tRNA consists of loops and helices
including the acceptor, anticodon and T stems, as well as
TyC (T), dihydrouridine (D) and anticodon loops. Unlike
canonical tRNAs such as human cytosolic tRNAs, human
mitochondrial tRNAs have specific features such as
non-classical G-U pairs and mismatches (Florentz et al.,
2003; Helm et al., 2000). As shown in Figure 1, there are
three types of unusual secondary structures in the mito⁃
chondrial tRNAs (Florentz et al., 2003; Suzuki et al.,
2011). The tRNASer(UCN) has a noncanonical cloverleaf
structure with only one base (A9) between the acceptor
stem and D stem, a short D loop and an extra loop, and
an extended anticodon stem with 6 bp . The tRNASer(AGY)
lacks the entire D loop. The other tRNAs do not have the
canonical D-loop/T-loop interaction. There are the
variable sizes and sequence of the D-loops and T-loops
in these tRNAs. Furthermore, mitochondrial tRNAs
undergo several important post-transcriptional modifica⁃
tions to ensure themselves correctly folded and fully func⁃
tional (Wang et al., 2010; Suzuki et al., 2011). However,
mitochondrial tRNAs contain less numbers of modified
nucleotides than those in cytoplasmic tRNAs (Suzuki et
al., 2011).
Figure 1 Schematic secondary structures of human mitochondrial
tRNAs. Canonical tRNA and three types of mitochondrial tRNAs
are shown. Circled numbers represent the nucleotide positions ac⁃
cording to the conventional tRNA numbering system (Sprinzl et al.,
1998). Tertiary interactions between nucleobases are indicated by
dotted lines.
Mitochondrial tRNA mutations associated with
deafness
Up to date, approximately 50 mutations in the tRNA
genes have been associated with deafness (Ruiz-Pesini
et al., 2007), as shown in Figure 2 and Table 1. Mutations
in the tRNA genes are associated with syndromic deafness
(hearing loss, accompanied with other syndromes such as
diabetes, myopathy, cardiomyopathy and encephalopathy)
or non-syndromic deafness (only deafness phenotype).
The syndromic deafness-associated tRNA mutations such
as tRNALeu(UUR) 3243A>G are often present in heteroplasmic
Figure 2 Mitochondrial tRNA mutations associated with deafness. The syndromic hearing loss associated mutations are indicated by black.
The gray denotes the mutations involved in non-syndriomic hearing loss. The secondary mutations are indicated by rectangle boxes.
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form, while non-syndromic deafness-associated tRNA
mutations including tRNASer(UCN) 7445A>G are often in
homoplasmy and in high levels of heteroplasmy (Fisch⁃
el-Ghodsian, 2004; Guan , 2004). Some tRNA muta⁃
tions referred to as the primary mutations such as
tRNALeu(UUR) 3243A>G and tRNASer(UCN) 7445A>G, are the
primary factors for the development of deafness (Reid et
al., 1994; van den Ouweland et al., 1992). On the
contrary, the secondary mutations are insufficient to
produce a deafness phenotype by themselves, but have a
potential modifier role in the phenotypic manifestation of
the primary mtDNA mutation. For instance, the tRNAThr
15927G>A and tRNASer(UCN) 7444G>A mutations act in
synergy with the primary 12S rRNA 1555A>G mutation,
thereby leading to a deafness phenotype (Yuan et al.,
2007; Wang et al., 2008).
Table 1 Mitochondrial tRNA mutations associated with deafness
Classification
Syndromic deafness
Non-syndromic deafness
Gene
tRNALeu(UUR)
tRNASer(UCN)
tRNALys
tRNALeu(CUN)
tRNAGlu
tRNAAla
tRNACys
tRNASer(UCN)
tRNAArg
tRNAHis
tRNASer(AGY)
tRNAGlu
tRNAThr
Mutation
3243G
3291C
7472insC
7472C
8344G
8356C
8363A
12300A
14709C
5587C
5655C
5802C
5821A
7444A
7445G
7505C
7511C
10454C
12201C
12224T
14693G
15908C
15927A
Manifestation
MIDD/MELAS/MERRF/CPEO
Progressive degeneration of
cognitive behavior, deafness
Deafness, ataxia and myoclonus
Myopathy, diabetes, mental
retardation, ataxia and deafness
MERRF
MELAS,MERRF
Encephalomyopathy, deafness and
hypertrophic cardiomyopathy.
MELAS
MIDD, myopathy
Deafness
Deafness
Aminoglycoside ototoxicity and
non-syndromic deafness
Aminoglycoside ototoxicity and
non-syndromic deafness
Aminoglycoside ototoxicity and
non-syndromic deafness
Deafness with or without
palmoplantar keratoderma
Deafness
Deafness
Aminoglycoside ototoxicity
and deafness
Deafness
Aminoglycoside ototoxicity
and deafness
Aminoglycoside ototoxicity
and deafness
Aminoglycoside ototoxicity
and deafness
Aminoglycoside ototoxicity
and deafness
Homoplasmy/
Heteroplasmy
Heteroplasmy
Heteroplasmy
Homoplasmy/
Heteroplasmy
Homoplasmy/
Heteroplasmy
Heteroplasmy
Heteroplasmy
Heteroplasmy
Heteroplasmy
Homoplasmy/
Heteroplasmy
Homoplasmy
Homoplasmy
Homoplasmy
Homoplasmy
Homoplasmy
Homoplasmy/
Heteroplasmy
Homoplasmy
Homoplasmy/
Heteroplasmy
Homoplasmy
Heteroplasmy
Homoplasmy
Homoplasmy
Homoplasmy
Homoplasmy
Primary/
Secondary
Primary
Primary
Primary
Secondary
Primary
Primary
Primary
Secondary
Primary
Secondary
Secondary
Secondary
Secondary
Primary/
Secondary
Primary
Primary
Primary
Secondary
Primary
Secondary
Secondary
Secondary
Secondary
References
Deschauer et al., 2001;
Lu et al., 2006;
van den Ouweland et al., 1992
Salsano et al., 2011
Kirino et al., 2005
Tiranti et al., 1995;
Hutchin et al., 2001
Cardaioli et al., 2006;
Swalwell et al., 2008
Shoffner et al., 1990
Zeviani et al., 1993
Santorelli et al., 1996
El Meziane et al., 1998;
Yasukawa et al., 2000
Rigoli et al., 2001;
Perucca-Lostanlen et al., 2002
Tang et al., 2010
Sue et al., 1999;
Li et al., 2004
Lu et al., 2010
Lu et al., 2010
Zhu et al., 2006;
Jin et al., 2007;
Yuan et al., 2007
Reid et al., 1994;
Maasz et al., 2008
Tang et al., 2010
Sue et al., 1999;
Chapiro et al., 2002;
Li et al., 2005;
Lu et al., 2010
Yan et al., 2011
Lu et al., 2010
Lu et al., 2010
Lu et al., 2010
Wang et al., 2008;
Lu et al., 2010
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tRNA mutations associated with syndromic deafness
tRNALeu(UUR) mutations
The 3243A>G mutation causes mitochondrial encepha⁃
lomyopathy, lactic acidosis, and stroke-like symptoms
(MELAS) (Goto et al., 1990) and is also one of the important
causes of maternally inherited diabetes and deafness
(MIDD) (van den Ouweland et al., 1992; Lynn et al.,
1998). The primary defect in this mutation was an inefficient
aminoacylation of the tRNALeu(UUR) (El Meziane et al.,
1998; Chomyn et al., 2000). This mutation also affected
the processing of the longer RNA precursors (Levinger et
al, 2004; Li and Guan, 2010) and the base post-transcrip⁃
tional modification of the tRNALeu(UUR) (Yasukawa et al.,
2000). In cybrids harboring the nearly homoplasmic
3243A>G mutation, the level of aminoacylated tRNALeu
(UUR) was reduced approximately 70% to 75% (Chomyn et
al., 2000; Li and Guan, 2010). The deficient aminoacyla⁃
tion of tRNALeu(UUR) mainly contributed to a shortage of
tRNALeu(UUR) (Chomyn et al., 2000; Li and Guan, 2010),
thereby causing the reduced rate of mitochondrial protein
synthesis and respiration defects. Additionally, the
3243A>T, 3264T>C and 3291T>C mutation in this tRNA
gene causing a decreased mitochondrial translation by
wobble modification deficiency, has also been associated
with syndromic deafness (Salsano et al., 2011; Kirino et
al., 2005; Suzuki et al., 1997).
tRNALys mutation
The 8344A>G, 8356T>C and 8363G>A mutations in
the tRNALys gene are responsible for myoclonic epilepsy
with ragged red fibers (MERRF), compatible with hearing
loss (Santorelli et al., 1996; Shoffner et al., 1990; Zeviani
et al., 1993; Masucci et al.,1995; Virgilio et al., 2009;
Levinger et al., 2004). The decreases of the steady-state
levels and aminoacylation in the tRNALys were observed
in cybrid cell lines carrying the 8344A>G mutation
(Enriquez et al., 1995). Furthermore, the lack of wobble
modification induced by 8344A>G mutation disturbed
condon-anticodon pairing in mutant tRNALys (Yasukawa
et al., 2001). Alteration in this tRNA metabolism is
apparently responsible for the defect of mitochondrial
translationandrespiration (Enriquezetal., 1995; Yasukawa
et al., 2001).
tRNASer(UCN) mutations
The 7472insC mutation has been reported in several
pedigrees with hearing loss, either in isolation or in
combination with ataxia, dysarthria, and, more rarely,
focal myoclonus (Tiranti et al., 1995; Hutchin et al.,
2001). Cybrid cells harboring homoplasmic 7472insC
mutation exhibited a marked decrease (~70%) of tRNASer
(UCN) abundance by affecting its synthesis rather than its
structure stability and also a mild decline (~25% ) in
steady-state aminoacylation of tRNASer(UCN) (Toompuu et
al., 2002).
tRNAGlu mutation
The 14709T>C mutation in the tRNAGlu has been
reported in two unrelated pedigrees with syndromic hearing
loss. Functional analysis in the cybrids carried 14709T>
C mutation showed a subtle decrease in the steady-state
levels of tRNAGlu transcripts (Rigoli et al., 2001; Peruc⁃
ca-Lostanlen et al., 2002). However, the pathogenecity of
the mutation need to be further understanding by func⁃
tional evaluations.
Primary tRNA mutations associated with non-syndromic
deafness
tRNASer(UCN) mutations
The tRNASer(UCN) gene is the hot spot for mutations
associated with non-syndromic deafness (Guan, 2004).
These mutations include the 7445A>G (Reid et al., 1994)
7511T>C (Sue et al., 1999), 7505T>C (Tang et al. 2010),
7445A>C, 7445A>T (Chen et al., 2008; Jin et al., 2007)
mutations. The primary defect of tRNASer(UCN) mutations
appeared to cause a failure in tRNA metabolism, thereby
altering mitochondrial translation and respiration (Guan
et al., 1998; Li et al., 2004). Furthermore, these mutations
often occur in homoplasmy or in high levels of heteroplasmy,
indicating a high threshold for pathogenicity (Guan et al.,
1998; Li et al., 2004; Tang et al., 2010).
The 7445A>G mutation in the precursor of tRNASer(UCN)
gene was associated with deafness in several genetically
pedigrees from Scotland, New Zealand, France, Ukraine,
Hungary and Japan with or without palmoplantar kerato⁃
derma (Reid et al., 1994; Fischel-Ghodsian et al., 1995;
Sevior et al., 1998; Maasz et al., 2008). The mutation
changed a frameshift signal (AGA) into AGG of the cyto⁃
chrome oxidase subunit I (COI) on the heavy (H) strand
(Temperley et al., 2010). At the same time, it changes
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L-strand encoded tRNASer(UCN) precursor sequence G↓
UCU (↓ indicates the in vitro 3’-tRNase processing
site) to G↓CCU, which resembles a 3’-tRNase anti-de⁃
terminant leading to the 3’end endonucleolytic processing
defect (Guan et al., 1998; Levinger et al., 2001). In fact,
the markedly reduced steady-state levels of tRNASer(UCN)
and ND6 mRNA belonging to the same precursor of
L-strand transcript were observed in cells carrying the
7445A>G mutation (Guan et al., 1998: Li et al.2005b).
The altered processing of RNA procurers impaired the
rate of synthesis of the ND6 subunit and plays a determi⁃
nant role in the deafness-associated respiratory pheno⁃
type of the mutant cell lines. In particular, it accounts for
their specific, very significant decrease in glutamate- or
malate-dependent O2 consumption (Guan et al., 1998; Li
et al., 2005b).
The 7511T>C mutation was associated with non-syn⁃
dromic hearing loss in several families from different
ethnic groups, including African, French and Japanese
(Chapiro et al., 2002; Li et al., 2005a; Sue et al., 1999).
The 7511T>C mutation converted a highly conserved
A-U to a G-U base pairing on the 5’side of the acceptor
stem of the tRNASer(UCN) (Florentz et al., 2003; Li et al.,
2004). Cybrids derived from an affected matrilineal
relative carrying the 7511T>C mutation exhibited ~75%
decrease in the steady state level of tRNASer(UCN), compared
with control cybrids (Li et al., 2004). This amount of
reduction in the tRNASer(UCN) level is below a proposed
threshold to support a normal rate of mitochondrial
protein synthesis. This defect is likely a primary contributor
to ~52% reduction in the rate of mitochondrial protein
synthesis and mitochondrial dysfunction (Li et al., 2004).
The 7505T>C mutation was identified in a Han
Chinese pedigree with maternally transmitted non-syn⁃
dromic deafness (Tang et al., 2010). This mutation is
located at a highly conserved base-pairing (10A-20U) of
tRNASer(UCN). The abolishment of 10A-20U base-pairing
likely alters the tRNASer(UCN) metabolism. Functional signif⁃
icance of this mutation was supported by ~65% reduc⁃
tions in the level of tRNASer(UCN) observed in the lympho⁃
blastoid cell lines carrying the 7505T>C mutation (Tang
et al., 2010).
tRNAHis 12201T>C mutation and mutations in other tRNAs
Most recently, a heteroplasmic tRNAHis 12201T>C
mutation has been identified in a large five-generation
Han Chinese pedigree with maternally transmitted
late-onset non-syndromic hearing loss (Yan et al.,
2011). Strikingly, the levels of heteroplasmic 12201T>C
mutation in cells correlated with the severity of hearing
loss. The 12201T>C mutation destabilizes a highly
conservative base-pairing (5A-68U) on the acceptor
stem of tRNAHis and may alter the secondary structure,
thereby causing a defect in the tRNA metabolism. Func⁃
tional characterization revealed a ~75% reduction in the
steady-state level of tRNAHis in 12201T>C mutant cell
lines, relative to the wild-type cell lines. The altered
tRNA metabolism led to the impairment of mitochondrial
translation and respiration responsible for the develop⁃
ment of deafness (Yan et al., 2011).
Secondary tRNA mutations
A variable phenotypes of hearing loss within and
among families carrying the same primary mtDNA muta⁃
tions such as the 1555A>G and 7445A>G mutations indi⁃
cated the involvement of modifiers including the secondary
mtDNA mutations (Lu et al., 2010; Maasz et al., 2008).
The secondary mutations in tRNA genes may enhance or
suppress the phenotypic manifestation of the primary
mtDNA mutations such as the 1555A>G mutation.
Enhancement of phenotypic expression of the primary
mtDNA mutations
Nine secondary tRNA mutations: tRNAThr 15927G>A,
tRNASer(UCN)/CO1 7444G>A, tRNACys 5802T>C, tRNAArg
10454T>C, tRNASer(AGY) 12224C>T, tRNACys 5821G>A,
tRNAGlu 14693A>G, and tRNAThr 15908T>C were impli⁃
cated to enhance the penetrance and expressivity of hearing
loss among 69 Chinese families carrying the 12S rRNA
1555A>G mutation (Young et al, 2006; Lu et al., 2010).
The penetrances and age-at-onset of hearing loss among
21 Chinese pedigrees carrying one of additional mtDNA
variants showed significantly higher or younger than 48
pedigrees lacking significant mtDNA variants, when
aminoglycoside-induced deafness was excluded. These
variants localized at highly conserved nucleotides of
tRNAs and may cause potential structural and functional
alterations. These mtDNA variants were present in
homoplasmy only on the maternal lineage in these
Chinese pedigrees and the allelic frequencies of these
variants were less than 1% in the Chinese controls
(Young et al., 2006, Chen et al., 2008 and Wang et al.,
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2008). In particular, the 15927G>A variant locates at
the fourth base in the anticodon stem (conventional
position 42) of the tRNAThr. A guanine (G42) at this
position of tRNAThr is highly conserved from bacteria to
human mitochondria (Sprinzl et al., 1998 and Florentz et
al., 2003). The abolished base-pairing (28C-42G) of this
tRNAThr by the 15927G>A mutation likely altered this
tRNA metabolism. Functional significance of this variant
was supported by the fact that the lower levels and altered
electrophoretic mobility of tRNAThr were observed in cells
carrying 1555A>G and 15927G>A mutations or only
15927G>A variant but not cells carrying only 1555A>G
mutation (Wang et al., 2008). Therefore, these deaf⁃
ness-associated secondary mutations may worsen mito⁃
chondrial dysfunctions caused by the 1555A>G mutation,
thereby increasing the penetrance and expressivity of
hearing loss in these Chinese pedigrees.
The tRNASer(UCN) 7511T>C mutation, in conjunction
with the ND1 3308T>C and tRNAAla 5655T>C mutations,
contributed to a higher penetance of hearing loss in a
large African family than these in Japanese and French
families (Chapiro et al., 2002; Li et al., 2004; Li et al.,
2005a; Sue et al., 1999). In fact, tRNAAla 5655T>C muta⁃
tions caused a significant decrease in the amount of
tRNAAla, while the ND1 3308T>C reduced the levels of
ND1 mRNA and co-transcribed tRNALeu(UUR) in mutant
cells, respectively (Li et al., 2004). As a consequence,
these two mutations worsened the mitochondrial dysfunc⁃
tion associated with the 7511T>C mutation, thereby
accounting for the higher penetrance of deafness in an
African family than Japanese and French families carrying
the same primary mutation (Chapiro et al., 2002; Li et al.,
2004; Li et al., 2005a). Furthermore, the tRNAAla 5587T>
C may play a role in the penetrance and expressivity of
the 7505T>C mutation (Tang et al., 2010).
Suppression of phenotypic expression of the primary mtD⁃
NA mutations
The 12300G>A mutation in the anticodon sequence of
the tRNALeu(CUN) was found in a lung carcinoma cybrid cell
line bearing 99% tRNALeu(UUR) 3243A>G mutant mtDNA
(El Meziane et al., 1998). In fact, the wild-type tRNALeu
(UUR) could efficiently decode both the UUA and UUG
codons, while the 3243A>G mutant tRNALeu(UUR) exhibited
the absence of taurine modification, resulting in a severe
reduction in UUG decoding, which was considered to be
the important molecular basis of MELAS syndrome (Yasu⁃
kawa et al., 2000). However, mass spectrometry analysis
showed that the suppressor 12300G>A mutation acquired
a de novo wobble uridine modification of UAA anticodon,
which could potentially decode UUR codons, thereby,
rescuing the severe impairment of both mitochondrial
translation and respiratory captivity caused by the
3243A>G mutation (Kirino et al., 2006).
The 7472A>C mutation at the tRNASer(UCN)gene appeared
to be suppressor of the primary 7472insC mutation at the
same gene in an Italian family with deafness (Cardaioli
et al., 2006). Despite harboring the same percentage of
7472insC mutation, the proband developed rapidly
progressive encephalopathy with deafness from a low
level of heteroplasmic 7472A>C mutation, while his
mother had only mild hearing impairment in associated
with higher percentage of 7472A>C (Cardaioli et al.,
2006). Subsequently, Swalwell et al showed that the
co-existing of the 7472A>C variation clearly influenced
the phenotypic expression associated with the 7472insC
mutation by trans-mitochondrial cybrids analysis (Swalwell
et al., 2008).
Mechanism of deafness associated tRNA mutations
Mitochondrial tRNA mutations have structural and
functional effects, including destabilization of tRNA
tertiary structure, altered processing of RNA precursors,
loss of nucleotide modification, deficient aminoacylation,
and reduced and mistaking anticodon-codon recognition.
Failures in tRNA metabolism caused by these mutations
led to mitochondrial protein synthesis, worsened by the
secondary tRNA mutations. These mitochondrial transla⁃
tional defects result in a decline in ATP production in the
cochlear and vestibular cells. At the same time, these
defects in oxidative phosphorylation would increase the
production of reactive oxygen species (ROS), thereby
damaging mitochondrial and cellular proteins, lipids and
nuclear acids. The hair cells and cochlear neurons may
be preferentially involved because they are somehow
exquisitely sensitive to subtle imbalance in cellular redox
state or increased level of free radicals. Consequently,
the mitochondrial permeability transition pore opens and
activates apoptosis. This would lead to the dysfunction or
death of cochlear and vestibular cells, thereby producing
the phenotype of hearing loss.
In summary, mutations in mitochondrial tRNAs represent
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an important basis for maternally inherited hearing loss
with or without additional symptoms. The primary
syndromic deafness-associated tRNA mutations, such as
tRNALeu(UUR) 3243A>G mutation involved with MELAS
and MIDD, are present at heteroplasmy with a typical
threshold effect. Furthermore, the levels of heteroplasmic
of these primary tRNA mutations are considered to be a
discriminator of the clinical phenotype and severity of the
disorder. However, the non-syndromic-deafness-associ⁃
ated tRNA mutations, including tRNASer(UCN) 7445A>G,
7511T>C mutations are often found in homoplasmy or in
high levels of heteroplasmy . These tRNA mutations are
the primary factors for the production of hearing loss,
while environmental factor(s), mtDNA haplotype(s) and
nuclear modifier gene(s) may have a modifying role in the
penetrance and expressivity of the deafness. In particular,
secondary tRNA mutations such as tRNAThr 15927G>A
and tRNASer(UCN) 7444G>A act in synergy with the primary
tRNA mutations, modulating the phenotypic manifesta⁃
tion.
Perspective
The genetic and biochemical evidences show that the
mitochondrial tRNA mutations are one of the important
causes of deafness. However, the pathogenic mechanism
of these tRNA mutations need to be further elucidated. In
particular, the tissue-specificity of these pathogenic
mtDNA mutations is likely due to tissue-specific RNA
processing, posttranscriptional modification or the contri⁃
bution of nuclear modifier genes. The establishment of
mice model for these mitochondrial tRNA mutations is a
critical approach for further understanding of molecular
mechanisms in pathogenesis of tRNA mutations. These
data will offer valuable information for the early diagnosis,
management and treatment of maternally inherited
hearing loss.
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